跳至主要内容
临床试验/ACTRN12612000352808
ACTRN12612000352808招募中2 期

A short term study of safety and glycaemic outcomes in haemodialysis patients with type 2 diabetes treated with metformin

Dr Tilenka Thynne0 个研究点目标入组 6 人开始时间: 2012年3月27日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • > 18 years
  • Type 2 Diabetes
  • Receiving haemodialysis 3 times a week for greater than 3 months
  • Patients in which metformin would normally be used if they had normal renal function.

排除标准

  • (1)Any patients in whom metformin would not be used in the setting of normal renal function including: Moderate to severe heart failure, liver failure, alcohol abuse, major psychiatric disorder, acutely unwell or otherwise medically unstable.
  • (2)Unable or unwilling to self monitor and record blood glucose levels via glucometer readings.
  • (3)Inability to provide written informed consent.

研究者

发起方
Dr Tilenka Thynne

相似试验